Xorte logo

News Markets Groups

USA | Europe | Asia | World| Stocks | Commodities



Add a new RSS channel

 

Keywords

2025-11-04 16:49:00| Fast Company

Shares in two closely watched AI-adjacent companies, Nvidia Corporation and Palantir Technologies, are falling this morning. Currently, Nvidia shares are down more than 2.2% and Palantir shares are down more than 6%. The share price drops of two of the most prominent AI companies come as investors seem increasingly worried that the AI boom is starting to look more like an AI bubble, reminiscent of the dotcom bubble of the late ’90s and early 2000s. In part due to these concerns, an increasing number of investors have recently begun betting against the stocks of companies benefitting from the artificial intelligence boomincluding Michael Burry, the investor who became famous for betting against the housing market before the 2008 financial crash. Heres what you need to know. “Big Short” investor bets against Nvidia and Palantir In the years leading up to the 2008 housing market crash, investor Michael Burry made a killing by shorting housing-related stocks after seeing signs of the then-upcoming housing market crash that few others noticed. In 2015, Burry was immortalized in The Big Short, the Oscar-winning film about the 2008 financial crash, in which he was played by Christian Bale. Burry has since gained a substantial following among some investors, and so his investment moves often gain widespread attention. Recently, his move has been to bet against the stock prices of Nvidia (Nasdaq: NVDA) and Palantir (Nasdaq: PLTR). As noted by Bloomberg, Bury’s Scion Asset Management recently revealed in a 13F regulatory filing that it bought put options on NVDA and PLTR. The news of Scion’s puts followed a Halloween post from Burry on X in which the hedge fund manager issued a cryptic post reading “Sometimes, we see bubbles. Sometimes, there is something to do about it. Sometimes, the only winning move is not to play,” along with an image of his Big Short character played by Bale. Burry’s puts seem to have struck a nerve with Palantir CEO Alex Karp, who on Tuesday told CNBC’s Squawk Box that the companies Burry is betting against “are the ones making all the money, which is super weird.” Karp added that “The idea that chips and ontology is what you want to short is batshit crazy. Then again, plenty of people thought Burry was crazy for shorting housing stocks in the years ahead of the 2008 crash. Palantir’s Tuesday share slide comes after the company reported Q3 earnings yesterday, in which it saw revenue climb 63%. The software company has been among the highest-growth stocks of 2025. Fears of an AI bubble loom large Regardless of whether Burry’s puts against Nvidia and Palantir end up being the right move, his move seems to have spurred at least some investors to offload NVDA and PLTR shares, as of the time of this writing. It should also be noted that Burry is far from the only one who sees signs of an AI bubble. Many investors and industry experts have begun to question whether the industry is in a bubbleand what would happen if that bubble pops.  For instance, an October Bank of America Global Research survey found that 54% of investors believe AI stocks are in a bubble, as Reuters recently reported. Even so, todays share price drops in NVDA and PLTR are minuscule compared to their surging stock prices in recent years. Year-to-date, Nvidia has seen its stock price surge more than 50% and PLTR is up more than 150%. Over the past 12 months, NVDA has risen more than 48% and PLTR has risen more than 350%. 


Category: E-Commerce

 

2025-11-04 16:15:00| Fast Company

A second food recall has been initiated after a California-based fruit supplier discovered that some of its yellow and white peaches might be contaminated with Listeria monocytogenes, which can cause potentially deadly infections. Here’s the latest and what to know: What’s happened? On October 29, Moonlight Companies voluntarily recalled “California-grown conventional” yellow and white peaches due to a risk of contamination with Listeria monocytogenes. Some items were sold under the Kroger name, the company said in its announcement.  Listeria was found in the packing facility. To date, no illnesses have been reported. However, the impacted fruit was sold at retail stores across the country. A day later, the Food and Drug Administration (FDA) published the recall notice on its website. A second peach-related recall was later announced due to potential Listeria contamination. On October 30, Supreme Producewhose supplier is Moonlight Companiessaid it recalled one peach salsa product.  To date, no illnesses have been reported. The FDA published this second recall notice on Monday. Which products are included in the recalls?  Recalled peaches were sold at retail stores nationwide between September 16 and October 29, 2025. They were sold individually with PLU stickers or in multi-packs. Peaches with packaging or PLU stickers with the words Organic or Washington arent included in the recall.  Recalled Moonlight Companies peaches include the following:  Moonlight Yellow Peaches Moonlight White Peaches Moonlight White Peaches (Peppermint Peach) Kroger Yellow Peaches You can see a full list of lot codes, PLU sticker numbers, and packaging images on the FDA’s website. The following Supreme Produce peach salsa product has been recalled:  Product: Peach Salsa Barcode UPC: 85006540364 Best by dates: 10/12/2025 to 10/29/2025 These products were packaged in 14-ounce clear, plastic grab-n-go containers and were sold in Kroger retail stores under the Supreme Produce brand.  They were distributed in the following states:  Arkansas Colorado Georgia Illinois Indiana Michigan  Mississippi  Oregon Tennessee Washington Discard remaining products  Customers should not consume any of the above recalled products. While theyre no longer for sale, if you have any of the above products, discard them. If you have any questions about the recall, call Moonlight Companies at (855) 215 -5017.  What is Listeria? Listeria infection is an illness caused by bacteria that can spread through contaminated food. According to the Mayo Clinic, healthy people rarely become seriously ill from Listeria infection.  However, the disease can be fatal for unborn babies, newborns, and those with weakened immune systems. Pregnant women, adults 65 and older, and people with weakened immune systems are most at risk for infection.


Category: E-Commerce

 

2025-11-04 15:16:46| Fast Company

Japanese video-game maker Nintendo’s net profit jumped 85% in April-September from the year before, as its sales more than doubled following the launch of its hit Switch 2 console in June, the company said Tuesday.Nintendo, based in Japan’s ancient capital of Kyoto, said its profit for the half-year totaled 198.9 billion yen, or $1.3 billion, up from 108.6 billion yen the year before.Sales for the first half of this fiscal year rose to nearly 1.1 trillion yen ($7.1 billion) from 523 billion yen in the same period of 2024.Nintendo, which makes Super Mario and Pokemon games, did not provide a break down of quarterly data.Nintendo’s video game sales were solid, although with no new movies revenue from its content business slowed.Nintendo raised its profit forecast for the full fiscal year through March 2026 to 350 billion yen ($2.3 billion). Previously, it had expected a 300 billion yen ($1.9 billion) profit.It also raised its forecast for Switch 2 machine sales to 19 million units from the earlier 15 million.Nintendo says it had sold more than 10 million Switch 2s by the end of September. Popular Switch 2 game software include “Mario Kart World” and “Donkey Kong Bananza.”Sales of the older Nintendo Switch have fallen, but Switch game sales are still going strong because they can be played on Switch 2 machines.Analysts expect Nintendo’s earnings to stay strong with the upcoming holiday season, when it tends to do well. They also expect key new games in the Pokemon and Kirby franchises.Nintendo stocks, which have been rising relatively steadily over the past year, fell 0.8% on Tuesday. Yuri Kageyama is on Threads: https://www.threads.com/@yurikageyama Yuri Kageyama, AP Business Writer


Category: E-Commerce

 

2025-11-04 14:35:00| Fast Company

The cloning industry is contractingironically, perhaps. On Tuesday, Colossal Biosciences announced that it has acquired ViaGen Pets and Equine, an animal cloning firm, marking Colossals first acquisition since it launched in 2021.  Texas-based Colossal Biosciences is best known for its controversial “de-extinction” endeavors, which involve efforts to recover species that have died out. Earlier this year, the company claimed to have “brought back” dire wolves, an assertion that was disputed by some experts, as the animals were created by modifying the DNA of existing gray wolves. The company has also sparked debates about the ethics of bringing species back from extinction, or if what it’s doing is in fact de-extinction at all. Either way, Colossal has attracted significant interest from high-powered investors, recently raising $120 million to try and resurrect the dodo. Its acquisition of ViaGen adds even more genetic firepower to its arsenal. Colossal is thrilled to welcome ViaGen, the worlds leading cloning company, into our portfolio, said Ben Lamm, founder and CEO of Colossal, in a statement provided to Fast Company. No other company comes close to what ViaGen has achieved. Their unmatched expertise and cloning technology stack have become the worlds standard and their application of these critical and proprietary technologies to endangered species conservation makes them an invaluable partner in advancing our global de-extinction and species preservation mission. Terms of the acquisition were not disclosed. Access to breakthrough technologies ViaGen, a Texas-based company founded in 2002, will continue to operate under its existing leadership and expand its endangered species cloning activity. Perhaps the most interesting element at play is ViaGens exclusive licensing and access to the breakthrough technologies developed by the Roslin Institute of Edinburghsuch as those that cloned Dolly the sheep, the first cloned mammal. Partnering with Colossal Biosciences presents an extraordinary opportunity to apply our advanced cryopreservation and cloning techniques to the ambitious goals of de-extinction and species restoration, said Dr. Shawn Walker, Ph.D., ViaGens chief science officer and known cloning expert, in a statement. Colossal has also attracted a stable of celebrity investors. Retired NFL star Tom Brady, for instance, worked with the company to clone his familys dog, and said in a statement that he is excited how Colossal and ViaGen’s tech together can help both families losing their beloved pets while helping to save endangered species. The potential to save endangered species is something that has others excited, too. Colossal shared a statement from filmmaker Peter Jackson, who said, These two companies together give humanity a real shot at saving the planet’s biodiversity.


Category: E-Commerce

 

2025-11-04 14:29:50| Fast Company

Denny’s said Monday that it’s being acquired by a group of investors in a deal that will take the breakfast chain private.Denny’s board unanimously approved the deal, which values Denny’s at $620 million including debt. Denny’s will be purchased by private equity investment company TriArtisan Capital Advisors, investment firm Treville Capital and Yadav Enterprises, which is one of Denny’s largest franchisees.Under the agreement, Denny’s shareholders will receive $6.25 per share in cash for each share of Denny’s common stock they own, or a total of $322 million. That represents a 52% premium to Denny’s closing stock price Monday.Denny’s shares jumped 47% in after-hours trading Monday.Denny’s was founded in 1953 in Lakewood, California, as Danny’s Donuts. The name was changed to Denny’s Coffee Shops in 1959 to avoid confusion with another chain. Denny’s began trading on the New York Stock Exchange in 1969.Like many casual chains, Denny’s saw its sales plummet during the COVID pandemic. Once the pandemic eased, it found itself dealing with changing customer dining patterns, including a heavier reliance on delivery. Denny’s has also struggled as newer chains like First Watch promoted healthier breakfast options.Last fall, Denny’s said it planned to close 150 of its lowest-performing locations. At the end of the second quarter, Denny’s had 1,558 restaurants worldwide, including 1,422 Denny’s restaurants and 74 Keke’s restaurants. Denny’s acquired the Keke’s brand in 2022.Denny’s CEO Kelli Valade said the company reached out to more than 40 potential buyers and received multiple offers. Valade said Denny’s board believed the deal announced Monday was in the best interest of shareholders and the best path forward for the company.TriArtisan Co-Founder and Managing Director Rhohit Manocha called Denny’s “an iconic piece of the American dream” with a strong franchise base and loyal customers.“We look forward to working with Kelli and the rest of the Denny’s team and franchisees to provide resources and support the Company’s long-term strategic growth plans,” Manocha said in a statement.If it’s accepted by Denny’s shareholders, the deal is expected to close in the first quarter of 2026. Dee-Ann Durbin, AP Business Writer


Category: E-Commerce

 

Sites : [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] next »

Privacy policy . Copyright . Contact form .